Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
630 | 13104 | 36.1 | 80% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
150 | 59286 | VIROLOGY//CYTOMEGALOVIRUS//EPSTEIN BARR VIRUS |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
231 | 3781 | CYTOMEGALOVIRUS//VALGANCICLOVIR//GANCICLOVIR |
342 | 3549 | HUMAN CYTOMEGALOVIRUS//HCMV//US28 |
2822 | 2064 | CONGENITAL INFECTION//CONGENITAL CYTOMEGALOVIRUS INFECTION//CYTOMEGALOVIRUS |
4377 | 1721 | HHV 6//HUMAN HERPESVIRUS 6//EXANTHEM SUBITUM |
12752 | 820 | MURINE CYTOMEGALOVIRUS//MCMV//LY49H |
13453 | 772 | CMV SPECIFIC T CELLS//ONCOHEMATOL GRP//CYTOMEGALOVIRUS SPECIFIC T CELLS |
32744 | 103 | IG LEVELS//LEUKEMIC CHILDREN//PROGNOSIS SURVIVAL |
33190 | 96 | C T USPHS//NULL CELLS//VIRUS THERMOSTABILITY |
33897 | 83 | VEGETABLE CELLS//ANAT PATHOL SERV 2//CICLO FORMAT ANAT PATOL CITOL |
34947 | 58 | GROSSING//MARGIN INKING//RESECTION LIMITS |
34956 | 57 | RHEUMATOID SYNOVIAL MEMBRANE//ANTITUMORAL IMMUNE RESPONSE//ANTITUMORAL IMMUNOTHERAPY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | Author keyword | 1116 | 45% | 14% | 1845 |
2 | HUMAN CYTOMEGALOVIRUS | Author keyword | 451 | 64% | 3% | 443 |
3 | HHV 6 | Author keyword | 376 | 78% | 2% | 247 |
4 | HUMAN HERPESVIRUS 6 | Author keyword | 353 | 70% | 2% | 291 |
5 | VALGANCICLOVIR | Author keyword | 224 | 75% | 1% | 164 |
6 | HCMV | Author keyword | 195 | 63% | 2% | 198 |
7 | CMV | Author keyword | 167 | 38% | 3% | 354 |
8 | CONGENITAL INFECTION | Author keyword | 153 | 58% | 1% | 179 |
9 | GANCICLOVIR | Author keyword | 138 | 34% | 3% | 329 |
10 | CONGENITAL CYTOMEGALOVIRUS INFECTION | Author keyword | 138 | 89% | 0% | 63 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOMEGALOVIRUS | 1116 | 45% | 14% | 1845 | Search CYTOMEGALOVIRUS | Search CYTOMEGALOVIRUS |
2 | HUMAN CYTOMEGALOVIRUS | 451 | 64% | 3% | 443 | Search HUMAN+CYTOMEGALOVIRUS | Search HUMAN+CYTOMEGALOVIRUS |
3 | HHV 6 | 376 | 78% | 2% | 247 | Search HHV+6 | Search HHV+6 |
4 | HUMAN HERPESVIRUS 6 | 353 | 70% | 2% | 291 | Search HUMAN+HERPESVIRUS+6 | Search HUMAN+HERPESVIRUS+6 |
5 | VALGANCICLOVIR | 224 | 75% | 1% | 164 | Search VALGANCICLOVIR | Search VALGANCICLOVIR |
6 | HCMV | 195 | 63% | 2% | 198 | Search HCMV | Search HCMV |
7 | CMV | 167 | 38% | 3% | 354 | Search CMV | Search CMV |
8 | CONGENITAL INFECTION | 153 | 58% | 1% | 179 | Search CONGENITAL+INFECTION | Search CONGENITAL+INFECTION |
9 | GANCICLOVIR | 138 | 34% | 3% | 329 | Search GANCICLOVIR | Search GANCICLOVIR |
10 | CONGENITAL CYTOMEGALOVIRUS INFECTION | 138 | 89% | 0% | 63 | Search CONGENITAL+CYTOMEGALOVIRUS+INFECTION | Search CONGENITAL+CYTOMEGALOVIRUS+INFECTION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CMV INFECTION | 734 | 80% | 4% | 460 |
2 | EXANTHEM SUBITUM | 707 | 87% | 3% | 351 |
3 | HHV 6 | 430 | 81% | 2% | 258 |
4 | CMV DISEASE | 430 | 84% | 2% | 235 |
5 | MURINE CYTOMEGALOVIRUS | 395 | 60% | 3% | 433 |
6 | PREEMPTIVE THERAPY | 368 | 78% | 2% | 240 |
7 | HUMAN HERPESVIRUS 6 | 344 | 50% | 4% | 492 |
8 | ORAL GANCICLOVIR | 340 | 72% | 2% | 267 |
9 | PP65 ANTIGENEMIA | 315 | 88% | 1% | 148 |
10 | HUMAN HERPESVIRUS 6 INFECTION | 300 | 71% | 2% | 243 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSPLANT INFECTIOUS DISEASE | 12 | 11% | 1% | 107 |
2 | CLINICAL AND DIAGNOSTIC VIROLOGY | 3 | 12% | 0% | 25 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The pathogenesis of human cytomegalovirus | 2015 | 8 | 80 | 86% |
Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection | 2007 | 289 | 67 | 97% |
The "Silent" Global Burden of Congenital Cytomegalovirus | 2013 | 55 | 186 | 97% |
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection | 2010 | 164 | 114 | 89% |
Classification of HHV-6A and HHV-6B as distinct viruses | 2014 | 16 | 122 | 98% |
New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection | 2007 | 214 | 26 | 100% |
Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review | 2014 | 15 | 64 | 91% |
Immunobiology of Human Cytomegalovirus: from Bench to Bedside | 2009 | 163 | 277 | 74% |
How I treat cytomegalovirus in hematopoietic cell transplant recipients | 2009 | 131 | 98 | 87% |
The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? | 2015 | 2 | 90 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERV VIROL | 28 | 20% | 1.0% | 125 |
2 | MED VIROL EPIDEMIOL VIRAL DIS | 23 | 51% | 0.2% | 32 |
3 | SPERIMENTALI RIC | 22 | 48% | 0.3% | 34 |
4 | ST ORSOLA GEN HOSP | 21 | 75% | 0.1% | 15 |
5 | INFECT DIS MICROBIOL TRANSLAT | 18 | 33% | 0.4% | 46 |
6 | SC OSTETRICIA GINECOL | 17 | 100% | 0.1% | 8 |
7 | KLIN MOL VIROL | 15 | 26% | 0.4% | 48 |
8 | ST ORSOLA MALPIGHI GEN HOSP | 14 | 55% | 0.1% | 18 |
9 | AREA TR IANTOL | 13 | 55% | 0.1% | 16 |
10 | VACCINE GENE THER Y | 13 | 18% | 0.5% | 64 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000011761 | HERPES SIMPLEX VIRUS//VARICELLA ZOSTER VIRUS//HERPES ZOSTER |
2 | 0.0000008533 | UVEITIS//CYTOMEGALOVIRUS RETINITIS//OCULAR IMMUNOLOGY AND INFLAMMATION |
3 | 0.0000007995 | KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KSHV |
4 | 0.0000007693 | NASOPHARYNGEAL CARCINOMA//EPSTEIN BARR VIRUS//EBV |
5 | 0.0000007161 | LUNG TRANSPLANTATION//BRONCHIOLITIS OBLITERANS SYNDROME//CHRONIC LUNG ALLOGRAFT DYSFUNCTION |
6 | 0.0000006888 | HLA G//KIR//NKG2D |
7 | 0.0000006850 | LIPODYSTROPHY//HIV ASSOCIATED NEPHROPATHY//LIPOATROPHY |
8 | 0.0000005221 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
9 | 0.0000005204 | EPIDEMIC KERATOCONJUNCTIVITIS//HIGH LEVEL DISINFECTION//OPHTHALMOLHOWE |
10 | 0.0000003940 | IMMUNOSENESCENCE//NUTRIENT MIXTURE//IMMUNITY & AGEING |